Literature DB >> 11875173

Delayed diagnosis of retinoblastoma: analysis of degree, cause, and potential consequences.

Linda J Butros1, David H Abramson, Ira J Dunkel.   

Abstract

OBJECTIVE: To assess the degree, cause, and consequence of delays from presenting signs to diagnosis of retinoblastoma.
METHODS: A retrospective chart review was conducted of 64 consecutive patients who presented to the Memorial Sloan-Kettering Cancer Center with newly diagnosed retinoblastoma. Seven patients with a positive family history were excluded.
RESULTS: The median times from presenting signs to diagnosis for patients with unilateral and bilateral disease were 1.5 and 2.25 months (range: 0--46), respectively; for those who presented with leukocoria and strabismus, median times were 1.5 (range: 0--46) and 2.5 months (range: 0--24). Parents noted the first signs in 75% of the cases. Seventy-seven percent delayed seeking treatment, and primary care physicians (PCPs) delayed referral in 30%. Only 3 patients were referred from PCPs solely for physical examination findings. No adverse consequence of delayed diagnosis could be established clearly, but a trend toward eye loss being associated with longer delays in patients with bilateral retinoblastoma was noted.
CONCLUSION: Leukocoria and strabismus secondary to retinoblastoma are usually first recognized by relatives rather than PCPs. At routine visits, PCPs should inform parents about the importance of reporting eye abnormalities, and children whose parents complain of leukocoria (white, shiny, jello-like eye) should be referred promptly to an ophthalmologist regardless of whether an absent red reflex is appreciated.

Entities:  

Mesh:

Year:  2002        PMID: 11875173     DOI: 10.1542/peds.109.3.e45

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

1.  Retinoblastoma referral pattern in Kenya.

Authors:  Joseph M Nyamori; Kahaki Kimani; Margaret W Njuguna; Helen Dimaras
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Oct-Dec

2.  Preserving vision in retinoblastoma through early detection and intervention.

Authors:  Sidnei Epelman
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

3.  Diagnostic delay and sociodemographic predictors of stage at diagnosis and mortality in unilateral and bilateral retinoblastoma.

Authors:  Marco A Ramírez-Ortiz; M Veronica Ponce-Castañeda; M Lourdes Cabrera-Muñoz; Aurora Medina-Sansón; Xinhua Liu; Manuela A Orjuela
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-12       Impact factor: 4.254

Review 4.  Retinoblastoma and Neuroblastoma Predisposition and Surveillance.

Authors:  Junne Kamihara; Franck Bourdeaut; William D Foulkes; Jan J Molenaar; Yaël P Mossé; Akira Nakagawara; Andreu Parareda; Sarah R Scollon; Kami Wolfe Schneider; Alison H Skalet; Lisa J States; Michael F Walsh; Lisa R Diller; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

5.  The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy.

Authors:  Yacoub A Yousef; Mona Mohammad; Mustafa Mehyar; Iyad Sultan; Maysa Al-Hussaini; Joud Alhourani; Hadeel Halalsheh; Jakub Khzouz; Imad Jaradat; Ibrahim Qaddoumi; Ibrahim Al-Nawaiseh
Journal:  J Pediatr Hematol Oncol       Date:  2021-08-01       Impact factor: 1.170

Review 6.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

7.  Characteristics of Germline and Non-germline Retinoblastomas.

Authors:  Fariba Ghassemi; Hormoz Chams; Siamak Sabour; Reza Karkhaneh; Farzad Farzbod; Mehdi Khodaparast; Parvaneh Vosough
Journal:  J Ophthalmic Vis Res       Date:  2014-04

8.  Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes.

Authors:  Meaghann S Weaver; Christina L Heminger; Catherine G Lam
Journal:  BMC Public Health       Date:  2014-09-11       Impact factor: 3.295

9.  Detection of leukocoria using a soft fusion of expert classifiers under non-clinical settings.

Authors:  Pablo Rivas-Perea; Erich Baker; Greg Hamerly; Bryan F Shaw
Journal:  BMC Ophthalmol       Date:  2014-09-09       Impact factor: 2.209

10.  Consequences of delayed diagnosis in treatment of retinoblastoma.

Authors:  Mohammad Faranoush; Amir Abbas Hedayati Asl; Azim Mehrvar; Narjes Mehrvar; Rokhsaneh Zangooei; Ehsan Abadi; Mardawig Alebouyeh; Maryam Tashvighi
Journal:  Iran J Pediatr       Date:  2014-07-30       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.